BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19773259)

  • 1. Genome wide molecular analysis of minimally differentiated acute myeloid leukemia.
    Silva FP; Almeida I; Morolli B; Brouwer-Mandema G; Wessels H; Vossen R; Vrieling H; Marijt EW; Valk PJ; Kluin-Nelemans HC; Sperr WR; Ludwig WD; Giphart-Gassler M
    Haematologica; 2009 Nov; 94(11):1546-54. PubMed ID: 19773259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status.
    Silva FP; Swagemakers SM; Erpelinck-Verschueren C; Wouters BJ; Delwel R; Vrieling H; van der Spek P; Valk PJ; Giphart-Gassler M
    Blood; 2009 Oct; 114(14):3001-7. PubMed ID: 19666867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes.
    Greif PA; Konstandin NP; Metzeler KH; Herold T; Pasalic Z; Ksienzyk B; Dufour A; Schneider F; Schneider S; Kakadia PM; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK
    Haematologica; 2012 Dec; 97(12):1909-15. PubMed ID: 22689681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
    Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
    Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent coexistence of RAS mutations in RUNX1-mutated acute myeloid leukemia in Arab Asian children.
    Al-Kzayer LF; Sakashita K; Al-Jadiry MF; Al-Hadad SA; Uyen le TN; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Hasan JG; Al-Abdullah HM; Inoshita T; Kamata M; Sughayer MA; Madanat FF; Koike K
    Pediatr Blood Cancer; 2014 Nov; 61(11):1980-5. PubMed ID: 25066867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis.
    Schnittger S; Dicker F; Kern W; Wendland N; Sundermann J; Alpermann T; Haferlach C; Haferlach T
    Blood; 2011 Feb; 117(8):2348-57. PubMed ID: 21148331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AML1/RUNX1 gene point mutations in childhood myeloid malignancies.
    Migas A; Savva N; Mishkova O; Aleinikova OV
    Pediatr Blood Cancer; 2011 Oct; 57(4):583-7. PubMed ID: 21294243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation.
    Wang K; Zhou F; Cai X; Chao H; Zhang R; Chen S
    Hematology; 2020 Dec; 25(1):211-218. PubMed ID: 32476595
    [No Abstract]   [Full Text] [Related]  

  • 9. RUNX1 Mutations Can Lead to Aberrant Expression of CD79a and PAX5 in Acute Myelogenous Leukemias: A Potential Diagnostic Pitfall.
    Menter T; Lundberg P; Wenzel F; Dirks J; Fernandez P; Friess D; Dirnhofer S; Tzankov A
    Pathobiology; 2019; 86(2-3):162-166. PubMed ID: 30396184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia.
    Khan M; Cortes J; Kadia T; Naqvi K; Brandt M; Pierce S; Patel KP; Borthakur G; Ravandi F; Konopleva M; Kornblau S; Kantarjian H; Bhalla K; DiNardo CD
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28933735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
    Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
    Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype.
    Akagi T; Ogawa S; Dugas M; Kawamata N; Yamamoto G; Nannya Y; Sanada M; Miller CW; Yung A; Schnittger S; Haferlach T; Haferlach C; Koeffler HP
    Haematologica; 2009 Feb; 94(2):213-23. PubMed ID: 19144660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia.
    Dicker F; Haferlach C; Kern W; Haferlach T; Schnittger S
    Blood; 2007 Aug; 110(4):1308-16. PubMed ID: 17485549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive mutational profiling of core binding factor acute myeloid leukemia.
    Duployez N; Marceau-Renaut A; Boissel N; Petit A; Bucci M; Geffroy S; Lapillonne H; Renneville A; Ragu C; Figeac M; Celli-Lebras K; Lacombe C; Micol JB; Abdel-Wahab O; Cornillet P; Ifrah N; Dombret H; Leverger G; Jourdan E; Preudhomme C
    Blood; 2016 May; 127(20):2451-9. PubMed ID: 26980726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype-specific patterns of molecular mutations in acute myeloid leukemia.
    Rose D; Haferlach T; Schnittger S; Perglerová K; Kern W; Haferlach C
    Leukemia; 2017 Jan; 31(1):11-17. PubMed ID: 27285584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.
    Tang JL; Hou HA; Chen CY; Liu CY; Chou WC; Tseng MH; Huang CF; Lee FY; Liu MC; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Lin LI; Tien HF
    Blood; 2009 Dec; 114(26):5352-61. PubMed ID: 19808697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
    Niimi H; Harada H; Harada Y; Ding Y; Imagawa J; Inaba T; Kyo T; Kimura A
    Leukemia; 2006 Apr; 20(4):635-44. PubMed ID: 16467864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation.
    Kuo MC; Liang DC; Huang CF; Shih YS; Wu JH; Lin TL; Shih LY
    Leukemia; 2009 Aug; 23(8):1426-31. PubMed ID: 19282830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes.
    Barresi V; Romano A; Musso N; Capizzi C; Consoli C; Martelli MP; Palumbo G; Di Raimondo F; Condorelli DF
    Genes Chromosomes Cancer; 2010 Nov; 49(11):1014-23. PubMed ID: 20725993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
    Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y
    Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.